Typicality: | 0.366 |
Saliency: | 0.271 |
months following the last trastuzumab dose | 6 | temporal |
on day 1 of cycles | 4 | temporal |
sample → be collected at → baseline | 11 |
sample → be taken at → baseline | 7 |
sample → be collected at → the baseline | 4 |
negative | neutral | positive |
0.099 | 0.829 | 0.073 |
Raw frequency | 22 |
Normalized frequency | 0.271 |
Modifier score | 0.500 |
Perplexity | 63.826 |